Articles

Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia

Department of Pediatric Oncology, Erasmus MC - Sophia Children’s Hospital, Rotterdam
Department of Pediatric Oncology, University Medical Center Utrecht;Princess Máxima Center for Pediatric Oncology, Utrecht
Department of Hematology, Erasmus Medical Center, Rotterdam, the Netherlands
Department of Hematology, Erasmus Medical Center, Rotterdam, the Netherlands
Department of Hematology, Erasmus Medical Center, Rotterdam, the Netherlands
Department of Pediatric Oncology, Erasmus MC - Sophia Children’s Hospital, Rotterdam
Department of Pediatric Oncology, Erasmus MC - Sophia Children’s Hospital, Rotterdam
Department of Hematology, Erasmus Medical Center, Rotterdam, the Netherlands
Princess Máxima Center for Pediatric Oncology, Utrecht
Department of Pediatric Oncology, Erasmus MC - Sophia Children’s Hospital, Rotterdam;Princess Máxima Center for Pediatric Oncology, Utrecht
Department of Hematology, Erasmus Medical Center, Rotterdam, the Netherlands
Vol. 104 No. 4 (2019): April, 2019 https://doi.org/10.3324/haematol.2018.193631